{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T19:23:19Z","timestamp":1777749799088,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["112535"],"award-info":[{"award-number":["112535"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.bioorg.2021.104839","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T01:23:23Z","timestamp":1616462603000},"page":"104839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Exploration of benzofuran-based compounds as potent and selective Plasmodium falciparum glycogen synthase kinase-3 (PfGSK-3) inhibitors"],"prefix":"10.1016","volume":"112","author":[{"given":"Chantalle","family":"Moolman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rencia","family":"van der Sluis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Beteck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesetja J.","family":"Legoabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.104839_b0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","article-title":"Kinase-targeted cancer therapies: progress, challenges and future directions","volume":"17","author":"Bhullar","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2021.104839_b0010","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/14737140.2018.1527688","article-title":"A comprehensive review of protein kinase inhibitors for cancer therapy","volume":"18","author":"Kannaiyan","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.bioorg.2021.104839_b0015","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.drudis.2014.05.008","article-title":"Protein kinase C inhibitors for immune disorders","volume":"19","author":"Altman","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2021.104839_b0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.tips.2014.09.007","article-title":"Advances in kinase targeting: current clinical use and clinical trials","volume":"35","author":"Rask-Andersen","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2021.104839_b0025","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.drudis.2014.03.028","article-title":"Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis","volume":"19","author":"Whang","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2021.104839_b0030","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2021.104839_b0035","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1021\/acs.jmedchem.8b00329","article-title":"Plasmodial kinase inhibitors: license to cure?","volume":"61","author":"Cabrera","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104839_b0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/138945007780058979","article-title":"Protein kinases as targets for antiparasitic chemotherapy drugs","volume":"8","author":"Canduri","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bioorg.2021.104839_b0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbapap.2003.11.021","article-title":"Protein kinases as targets for anti-parasitic chemotherapy","volume":"1697","author":"Doerig","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2021.104839_b0050","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pt.2008.08.007","article-title":"Protein kinases of malaria parasites: an update","volume":"24","author":"Doerig","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bioorg.2021.104839_b0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbapap.2005.08.027","article-title":"Protein kinases as targets for antimalarial intervention: kinomics, structure-based design, transmission-blockade, and targeting host cell enzymes","volume":"1754","author":"Doerig","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2021.104839_b0060","unstructured":"WHO (World Health Organization), World Malaria Report 2019. https:\/\/www.who.int\/malaria\/publications\/world_malaria_report\/en\/, 2019 (accessed 17 February 2020)."},{"key":"10.1016\/j.bioorg.2021.104839_b0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40249-019-0524-x","article-title":"Are malaria elimination efforts on right track? An analysis of gains achieved and challenges ahead","volume":"8","author":"Dhiman","year":"2019","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.bioorg.2021.104839_b0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/cbdd.13484","article-title":"Plasmodium falciparum: multidrug resistance","volume":"93","author":"Rout","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2021.104839_b0075","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2021.104839_b0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ncomms1558","article-title":"Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum","volume":"2","author":"Solyakov","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2021.104839_b0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2164-5-79","article-title":"Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote","volume":"5","author":"Ward","year":"2004","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bioorg.2021.104839_b0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbapap.2003.11.023","article-title":"Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors","volume":"1697","author":"Droucheau","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2021.104839_b0095","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","article-title":"Crystal structure of glycogen synthase kinase 3\u00df: Structural basis for phosphate-primed substrate specificity and autoinhibition","volume":"105","author":"Dajani","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2021.104839_b0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2021.104839_b0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A Phase II Trial of Tideglusib in Alzheimer's Disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bioorg.2021.104839_b0110","article-title":"Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment","volume":"2011","author":"Martinez","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.bioorg.2021.104839_b0115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.2008.00085.x","article-title":"Glycogen synthase kinase 3: more than a namesake","volume":"156","author":"Rayasam","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.104839_b0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/14786419.2014.947496","article-title":"Dispacamide E and other bioactive bromopyrrole alkaloids from two Indonesian marine sponges of the genus Stylissa","volume":"29","author":"Ebada","year":"2015","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2021.104839_b0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/jm301575n","article-title":"3,6-Diamino-4-(2-halophenyl)-2-benzoylthieno[2,3-b]pyridine-5-carbonitriles are selective inhibitors of Plasmodium falciparum glycogen synthase kinase-3","volume":"56","author":"Fugel","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104839_b0130","first-page":"1644","article-title":"Selective inhibitors of Plasmodium falciparum glycogen synthase-3 (PfGSK-3): New antimalarial agents?","volume":"2015","author":"Masch","year":"1854","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2021.104839_b0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/qsar.200860193","article-title":"Comparative investigation of the ATP-binding site of human and plasmodial glycogen synthase kinase-3","volume":"28","author":"Kruggel","year":"2009","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.bioorg.2021.104839_b0140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1017\/S0031182011000151","article-title":"Bioinformatic analysis of glycogen synthase kinase 3: human versus parasite kinases","volume":"138","author":"Osolodkin","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.bioorg.2021.104839_b0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12936-019-2725-y","article-title":"Structure-activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines","volume":"18","author":"Masch","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.bioorg.2021.104839_b0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/chem.201303273","article-title":"Total synthesis of (+\/-)-frondosin B and (+\/-)-5-epi-liphagal by using a concise (4+3) cycloaddition approach","volume":"20","author":"Laplace","year":"2014","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2021.104839_b0155","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1021\/jo00382a018","article-title":"Hydroxyl-directed regioselective monodemethylation of polymethoxyarenes","volume":"52","author":"Lal","year":"1986","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2021.104839_b0160","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1021\/jm500833f","article-title":"Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system","volume":"57","author":"Bellale","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104839_b0165","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1021\/jo01035a003","article-title":"Selective bromination with copper (II) bromide","volume":"29","author":"King","year":"1964","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2021.104839_b0170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00304948.2013.816214","article-title":"Polyethylene glycol (PEG-400) as an efficient and recyclable reaction medium for the synthesis of 2-aroylbenzofurans","volume":"45","author":"Zhao","year":"2013","journal-title":"Org. Prep. Proced. Int."},{"key":"10.1016\/j.bioorg.2021.104839_b0175","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.bmcl.2014.04.021","article-title":"\u03b1-Tetralone derivatives as inhibitors of monoamine oxidase","volume":"24","author":"Legoabe","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104839_b0180","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1089\/adt.2009.0230","article-title":"Comparison of bioluminescent kinase assays using substrate depletion and product formation","volume":"7","author":"Tanega","year":"2009","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.bioorg.2021.104839_b0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/jbc.M002466200","article-title":"Indirubins inhibit glycogen synthase kinase-3 beta and CDK5\/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?","volume":"276","author":"Leclerc","year":"2001","journal-title":"J. Biol. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821002169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821002169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:53:21Z","timestamp":1777463601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821002169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":37,"alternative-id":["S0045206821002169"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104839","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of benzofuran-based compounds as potent and selective Plasmodium falciparum glycogen synthase kinase-3 (PfGSK-3) inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104839"}}